Multiple System Atrophy

Multiple System Atrophy (MSA) is a rare neurodegenerative disorder which affects the body’s autonomic functions, including breathing and muscle control. Discover the latest research on MSA here.

July 19, 2020

Non-motor symptoms of Parkinson's disease from pathophysiology to early diagnosis

La Revue de médecine interne
M AubignatP Krystkowiak
August 11, 2020
Open Access

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia

Tremor and Other Hyperkinetic Movements
Shin-Ichi UenoNobutaka Hattori
July 19, 2020
Open Access

Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models

Journal of Neuroinflammation
Michiyo IbaEliezer Masliah
July 24, 2020

Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Giuseppe CosentinoEnrico Alfonsi
August 6, 2020
Open Access

Bilateral middle cerebellar peduncle lesions: Neuroimaging features and differential diagnoses

Brain and Behavior
Jiwei JiangXiuli Shang
August 6, 2020
Open Access

The Characteristics of Tremor Motion Help Identify Parkinson's Disease and Multiple System Atrophy

Frontiers in Neurology
Dongning SuTao Feng
July 19, 2020
Open Access

NfL as a biomarker for neurodegeneration and survival in Parkinson disease

Neurology
David BäckströmNiklas Lenfeldt
July 8, 2020
Open Access

FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)

Scientific Reports
Marwa ZafarullahFlora Tassone
July 10, 2020

Modeling Parkinson's Disease in Zebrafish

CNS & Neurological Disorders Drug Targets
Nor Haliza Mohamad NajibSeong Lin Teoh
July 11, 2020
Comment / Editorial
Open Access

Can skin biopsy differentiate Parkinson disease from multiple system atrophy? And other updates on recent autonomic research

Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
Mitchell G Miglis, Srikanth Muppidi
July 28, 2020

The footprint of orthostatic hypotension in parkinsonian syndromes

Parkinsonism & Related Disorders
Cecilia RaccagniAlessandra Fanciulli
July 10, 2020
Case Report
Open Access

Long term follow up after transorbital penetrating injury: A case report

American Journal of Ophthalmology Case Reports
Caroline VlokaSusan Stefko
August 6, 2020
Open Access

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017

Journal of Clinical Medicine
Maria Angela Samis ZellaLars Tönges
July 20, 2020
Review
Open Access

Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy

Stem Cell Research
Jin Young Shin, Phil Hyu Lee

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-system-atrophy/8113fe24-f62b-4d81-b0d3-069bcabfc12d